"However, there are logistical challenges as the vaccine has to be kept in ultra-cold storage at below minus 80C." Does anyone know how many of the other vaccine candidates have this limitation? It seems to me that a vaccine with easier logistics might still end up having a bigger impact overall, despite not being the first - although that of course needs to be combined with the ease of production too (I don't know h…
I know that several of the vaccine candidates require similarly cold storage for their entire distribution cycle until they are being used. Disclaimer: I work for big pharma.
I assume you aren't injecting people with something at -80C. How big of a window is there for injections?